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§  Primary missions 
§  Background 
§  Reduction of time for microbial detection 
and identification 
§  Non cultural approach & POCT 
§  Automation of culture process 
§  Medical microbiologist: the profession 




TO IMPROVE THE MANAGMENT OF INFECTIOUS DISEASE 
CONTRIBUTION TO DIAGNOSTIC 
Presence /absence of pathogens 
Identification +/- quantification 
 
CONTRIBUTION  TO CHOICE OF 
ANTIBIOTHERAPY 
Antimicrobial susceptibility testing, identification of resistance 
mechanisms and resistance genes 
 
SUPPORT TO INFECTION CONTROL 
 
To provide useful, accurate and relevant results 
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Useful results 
 
POSITIVE IMPACT ON 
 
§  Therapeutic decision? 
§  Optimized management of patients? 
§  Morbidity, mortality? 
§  Length of hospitalization? 
Reduction of Turn-Around-Time  
for result and its notification to clinician 
§  Control of nosocomial infections?    
§  Antibiotic consumption? 
§  Control of antimicrobial resistance?  
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Background 
To understand priorities for the future 
 
Medical evolutionary background 
 
Impact factors on development and daily 
practice of microbiology 
§  Economic environment 
§  Cost-effective use of available resources 
§  Trained human resources 
§  Population pyramid and labour shortage 
§  Medical environment 
§  Increasing emphasis on evidence-based medicine  
and adherence to guidelines 
§  Technological background 
§  Exponential progress: molecular biology and robots 
§  Quality assurance, traceability 
§  Global increase of antimicrobial resistance  
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  Global increase of antimicrobial resistance 
Emerging superbug 
 Invasive isolates in Europe : 2005 vs 2009 (EARSS-ECDC)  



















Antimicrobial selective pressure  
Abusive use of broad-spectrum antibiotics  
Delay to identifying MDR bacteria carrier = bad control of 
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Challenges greater than ever 
in all parts of the world 
§  Numbers of emerging infections 
§  AND Global increase of antimicrobial 
resistance  
§  AND Drug development pipeline for new 
antibiotics virtually empty !! 
THREAT within the next 10 years 
Shortage crisis of effective drugs for treating 
bacterial infection 
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European research priority 
To combat growing problem of antimicrobial R 
§  Multidisciplinary research 
§  EU Framework Programmes 
§  Studies on molecular mechanisms leading to 
emergence and spread of R genes 
§  Epidemiological studies with aim of developing 
control and preventive measures 
§  Translational, clinical and public health research 
§  For developing guidelines for evidence-based clinical 
practice and patient management: for prudent use of 
antibiotics  
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European research priority 
To combat growing problem of antimicrobial R 
§  EU Framework Programmes 
§  To promote the rational use of antibiotics 
§  Mobilization of European biotechnology industry to 
develop POC diagnostic tests 
§  For early identification and differentiation of infectious 
disease-causing agents 
§  To seek for novel molecular targets in pathogens 
and candidate drugs against them 
§  Strengthened Transatlantic cooperation 
§  Transatlantic Taskforce on Antimicrobial 
Resistance (TATFAR since 2009) 
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Reduction of time for 
microbial detection and 
identification 
 
“Need for speed” 
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Medical microbiology laboratory 
Challenges in 2011 
Turnaround time 














Delayed results are unhelpful for clinicians ! 
How could rapid bacterial identification improve 
the management of septic patients? 
“… every hour without adequate treatment in septic shock is clearly 
associated with a 7.6% decrease in survival …” 
§ Severe sepsis and septic shock 
§  Major motivation to identify bacteria present in blood quickly 
§  Tools exists for positive blood cultures (MALDI-TOF MS, PCR, 
microarray, …) but far more rapid needed 
§ Clinical impact of rapid ID even if not AST 
§  Clue towards primary site of infection and targeted 
investigation 
§  Reduction of empirical broad-spectrum antibiotics to a more 
narrow pre-emptive therapy treatment 
§  Based on usual susceptibility (or natural R) of pathogens 
§  If E.coli: stopping vancomycin and macrolides whenever 
prescribed 
Kumar et al, CCM 2006; Emonet et Schrenzel  Expert Rev Anti Inf Ther  2011      . 	
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Rapid identification of a pathogen 
Prime importance for effective provision of care 
to patients with infections 
§  Includes 
§  Use of rapid bedside diagnostic tests 
§  Need to be backed up by conventional culture techniques (for 
AST) 
§  Rapid reporting of results  
§  Pre-emptive culturing !! 
§  Molecular diagnostics 
§  Bacteremia is different from DNAemia 
§  Sometimes challenge to interpret 
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Identification and MALDI-TOF MS (>2009) 
§  20-years old technology 
§  Becomes the standard for ID 
§  < Isolated colonies  
§  < Positive blood cultures 
C.Meex’s poster 	

§  Bacteria, yeasts, fungi 
§  Results within a few minutes 
§  Results 24hours prior to  
conventional methods 
§  Interface LIS    
§  Cost-effective 
§  Clinical and therapeutic impacts 
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Various mass spectrometry methods & 
application in clinical microbiology 
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§  MALDI-TOF MS (Bruker; Shimadzu/bioMerieux) 
§  Bacterial ID 
§  More specific databases in development 
§  Virulence and resistance markers 
§  PCR-ESI-MS (Electro Spray Ionization), Plex-ID 
§  Directly from sample : DNA extraction 
§  4-6 hours 
§  Semi-quantitative ID of all organisms present including virus 
§  Syndromic panels of infection 
§  Coupled with amplification by PCR, broad range of primers 
§  High sensivity 
§  Detection of virulence or resistance genes  
§  Results // to microarrays but faster 
§  Still very expensive 
   
 
Various emerging applications of 
sequence-specific DNA amplification 
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§  PCR and Real-time PCR 
§  Single or multiplex 
§  Screening, detection and quantitative assays 
§  Loop-mediated isothermal AMPlification (LAMP) 
§  Direct detection 
§  Fast, sensitive, robust 
§  Salmonella, C.difficile, group B streptococci, …  
§  Broad-range 16S rDNA PCR followed by sequencing 
§  Major milestone in diagnostic of infectious disease 
§  Negative cultured bone and joint infections, endocarditis, 
Al Masalma et al., 2009; Fenollar and Raoult, 2007 	

   
 
Point of-care-test platforms for early 
diagnosis of infection 
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To provide an integrated solution addressing 
technological challenges 
§ For rapid detection of bacteria, mycobacteria, fungi, viruses, host 
markers and resistance to antimicrobial drugs 
§ To enhance clinical decision-making 
§ To improve quality of care and clinical outcomes 
§ To improve targeted therapy and reduce overuse  
§  Specific probes 
§  Novel methods of sample preparation 
§  Ultra-high sensitive detection methods 
Results availability  
in less than 2 hours/30 min for IN/OUT patients  
Point of-care-test platforms for early 
diagnosis of infection 
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Among EU funded projects 
§  RAPP-ID - Development of RApid Point-of-Care test 
Platforms for Infectious Diseases  
§  Bloodstream infections 
§  Lower respiratory tract infections 
§  Tuberculosis 
§  From Be: UIA, KUL, RUG and Imec 
§  C4L - Chips for Life 
§  Lower respiratory tract infections 
§  From Be: CHU-Ulg, UIA and Coris 
 
Huge challenges and synergies: 
Biotechnologies, microtecnologies and clinical practice 
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Automation of culture process 
 
 
Automation in bacteriology 
Medical and economical plus values 
§  Labour shortages  
§  Increasing test volumes 
§  Reduction of TAT 
§  Reduction of laboratory errors associated 
with specimen handling 
§  Full traceability 
§  Improved workflow  
§  Enhanced quality 	
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Availability of high-throughput robots 
§  Gradually being introduced into everyday microbiology 
diagnostics 






Automation in bacteriology 
Medical and economical plus values 
Most cost effective use of resources 
§  Rational throughput if 
§  Large volume of specimens 
§  Often centralisation of services 
§  Danger of large-scale microbiology labs  
§  Logistics rather than diagnostics  
§  Risk of lost of clinical focus on the patient 
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The ongoing challenge 
 
First fields of automation and improvement : 
bloodcultures and mycobacteria 





§  Continuous measures 
§  Earliness of detection 
§  Interface with LIS 
§  Evolution of culture broths 





    
     
  MGIT                    
Bactec 
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Since 2009 
Plating and inoculation of specimens  
§  Systems 
§  PREVITM Isola, 
bioMérieux 
§  WASP, Copan 
§  INNOVA, BD 
§  InoculA, Kiestra  
§  Semi-manual  
§  Full-automated 
 
   
 
§  Characteristics 
§  Media storage 
§  Types of specimen container  
§  Inoculation control 
§  Tips, swabs, volumes 
§  Plating method  
§  Streak patterns 
§  Traceability 
§  Biosecurity 
§  Sorting  
§  Interface with  LIS 
§  Integration in a chain 
§  Slide module 
§  Output: plates/hour  
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PREVITM Isola, bioMérieux 
§  Liquid specimen 
§  Tips  
§  1 pattern : comb 
§ Max of 5 different media 
§ 180 plates/h   
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WASP, Copan 
Slide module  (option) 
§  Liquid 
specimens 
§  1, 10 et 30 µl 
§ Max 9 media 
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InoqulA, Kiestra 
Semi- and Full-automated inoculation 
•  6 – 30  media 
•  Barcode labelling at side dish 
•  Full Automatic ( decap / cap, 
pipet ) in plates, slides and tubes 
•  Shaking / vortexing 
•  Manual Interactive inoculation 
•  All specimen types 
•  Sorting + Stacking for incubators  
•  300 – 500 inoculations per hour 
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«Future» : Total laboratory automation 
Kiestra,  Wasplab (Copan), bioMerieux concept 
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Transport 
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Incubation, digitized images of cultures 
24H/24, 7J/7 
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Reading 
- /patient 
- /type of specimen  
- /… 
Telebacteriology 
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Medical microbiologist 
To face the future 
 
Medical microbiologist  according to 
Union of European Medical Specialties (UEMS) 
Main tasks 
§  Advice on diagnosis, treatment and prevention of 
infections 
§  Implementation of antibiotic policy 
§  Generation of surveillance data 
To go to  
§  Integration of activities with Infectious Disease 
specialists to optimize the efficiency  
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Medical microbiologist  in Europe 
A specialty in many European countries 
§  Integrated training with Infectious disease 
§  Specialist’s mobility through Europe 
§  In Belgium 
§  > 10.2012 – A 2-year certificate in “Infectious 
disease and clinical microbiology” 
§  25 modules 
§  ULB, UCL and ULg 
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Mutations & a new culture are necessary to 
enjoy over the future of microbiology 
 §  Improving time to result   
§  Clinical impact only  if used without any further delay by 
clinicians 
§  Non-culture approach and back-up cultures 
§  Cost-effectiveness & clinical relevance still to show 
§  To develop and master technological advances 
§  Laboratory automation and improved workflow 
§  Avalanche of new methods for rapid diagnostics 
§  Increasing pressure for  
§  Concentration, amalgation and outsourcing of lab service 
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Each laboratory should carefully think about 
how they can positively reorganize 
to speed up the diagnostics 
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A lot of opportunities to enjoy 
over the next few years !  
 
 
Thank you  
 
